Gao Jin-Ming, Feng Qi-Ping, Zuo Jin, Fang Fu-De, Jiang Lei, Guo Zi-Jian
Department of Respiratory Diseases, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Apr;29(2):241-5.
To investigate the role of sulfated tyrosine in regulating the activity of tyrosylprotein sulfotransferases (TPST) 1 and TPST2.
Constructs of TPST 1 and TPST2 were amplified by polymerase chain reaction (PCR), then fused into immunoglobulin G1 Fc region. All the variants in which sulfated tyrosines were mutated to phenylalanine were made by the PCR-based Quick Change method and confirmed by sequencing the entire reading frame. Small hairpin RNA (shRNA) constructs-targeting nucleotides 259-275 of TPST1 and nucleotides 73-94 of TPST2 were generated and subcloned into pBluescript. Human embryonic kidney (HEK) 293T cells were transfected with these plasmids. One day later, cells were split: one part was labeled with 35S-cysteine and methionine or 35S-Na2SO3 overnight, the second part was used for 125I labeled binding experiment, and the third part was retained for binding and flow cytometry.
Tyrosines at position 326 of TPST1 and position 325 of TPST2 were sulfated posttranslationally. Tyrosine sulfation of TPSTs was effectively inhibited by sulfation inhibitors, including specific shRNAs and non-specific NaCIO3. shRNAs reduced the sulfation of C3a receptor and C5a receptor, and partially blocked the binding of these two receptors to their respective ligands.
The activities of TPSTs were regulated by tyrosine sulfation. Inhibition of sulfotyrosine decreases the binding ability of C3a receptor and C5a receptor to their respective ligands.
研究硫酸化酪氨酸在调节酪氨酰蛋白硫酸转移酶(TPST)1和TPST2活性中的作用。
通过聚合酶链反应(PCR)扩增TPST 1和TPST2的构建体,然后将其融合到免疫球蛋白G1 Fc区域。所有硫酸化酪氨酸突变为苯丙氨酸的变体均采用基于PCR的快速突变方法制备,并通过对整个阅读框进行测序来确认。构建靶向TPST1的259 - 275位核苷酸和TPST2的73 - 94位核苷酸的小发夹RNA(shRNA)构建体,并亚克隆到pBluescript中。将这些质粒转染到人胚肾(HEK)293T细胞中。一天后,将细胞传代:一部分用35S - 半胱氨酸和甲硫氨酸或35S - Na2SO3标记过夜,第二部分用于125I标记结合实验,第三部分保留用于结合和流式细胞术分析。
TPST1的326位酪氨酸和TPST2的325位酪氨酸在翻译后被硫酸化。TPSTs的酪氨酸硫酸化被硫酸化抑制剂有效抑制,包括特异性shRNAs和非特异性的NaClO3。shRNAs降低了C3a受体和C5a受体的硫酸化,并部分阻断了这两种受体与其各自配体的结合。
TPSTs的活性受酪氨酸硫酸化调节。抑制硫酸化酪氨酸会降低C3a受体和C5a受体与其各自配体的结合能力。